Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Kerlone*


Not recommended
Use with caution

Not recommended
As a precautionary measure
Kerlone* :
Type Medicine Non Marketed
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Sanofi
Responsible Party Sanofi Winthrop Industrie
Origin France
Manufacturer Sanofi Winthrop Industrie
Origin France
ATC C07AB05

Your comment will appear shortly after approval

Kerlone* :

Revision Date : 15/12/2015


Effect Frequency
Antinuclear antibody (ANA) positive Rare
Asthenia Common
Bradycardia Common
Bronchospasm Rare
Cardiac failure Rare
Cephalea Common
Cold extremities Common
Confusion Very rare
Depressive state Rare
Diarrhoea (Diarrhea) Common
Dry eye Rare
Gastralgia Common
Hallucination Very rare
Hyperglycaemia Very rare
Hypoglycaemia Very rare
Hypotension Rare
Impotence Common
Insomnia Common
Intermittent claudication aggravated Rare
Lethargy Not known
Nausea Common
Nightmares Very rare
Paraesthesia distal Very rare
Pruritus Not known
Psoriasis exacerbation Rare
Rash psoriaform Rare
Raynaud's phenomenon Rare
Skin reaction Rare
Sweating increased (Excessive sweating) (Hyperhydrosis) Not known
Systemic lupus erythematosus Rare
Urticaria Not known
Vertigo Common
Visual disturbance Very rare
Vomiting Common

Different Units By MoH Code

Revision Date : 01/06/2005

Revision Date : 01/07/2014

Kerlone* Kerlone* Kerlone* Kerlone* Kerlone* Kerlone*

Kerlone*  MoH 3027 :
Form Tablet, Film-Coated breakable
Packaging Blisters (Al/PVC)
Package Size Box of 28
Strength 20mg
NSSF ✘
Quarantine ✘
Reg. Number 26250
Submission date 01/01/1987
Registration Year 1987
Archived Date 02/03/2023


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info